27651178|t|HELLP Syndrome
27651178|a|The hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome is frequently observed in mothers whose offspring have long-chain fatty acid oxidation defects. We previously found that fatty acid oxidation is compromised not only in these inborn errors of metabolism but also in human umbilical vein endothelial cells (HUVECs) from all pregnancies complicated by the HELLP syndrome. Sirtuins are oxidized nicotinamide adenine dinucleotide (NAD(+))dependent deacetylases linked to the metabolic status of the cell. SIRT 4 is known to have regulatory functions in fatty acid oxidation. The HELLP syndrome is often associated with short-term hypoxia. We studied sirtuins (SIRT 1, SIRT 3, and SIRT 4) in HUVECs from pregnancies complicated by the HELLP syndrome and uncomplicated pregnancies exposed to hypoxia (n = 7 controls, 7 HELLP; 0, 10, 60, or 120 minutes of 2% O2). Protein levels of SIRT 4 were significantly higher in HUVECs from HELLP compared to control after 60 and 120 minutes of hypoxia. The NAD(+) levels increased in a time - dependent manner.
27651178	0	14	HELLP Syndrome	T047	C0162739
27651178	19	93	hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome	T047	C2903579
27651178	108	116	observed	T169	C1441672
27651178	120	127	mothers	T099	C0026591
27651178	134	143	offspring	T099	C0680063
27651178	149	170	long-chain fatty acid	T109,T123	C0522095
27651178	171	180	oxidation	T044	C0030011
27651178	181	188	defects	T169	C0243067
27651178	215	235	fatty acid oxidation	T044	C1158366
27651178	239	250	compromised	T033	C2945640
27651178	269	296	inborn errors of metabolism	T019,T047	C0025521
27651178	309	347	human umbilical vein endothelial cells	T025	C3179121
27651178	349	355	HUVECs	T025	C3179121
27651178	366	389	pregnancies complicated	T047	C0032962
27651178	397	411	HELLP syndrome	T047	C0162739
27651178	413	421	Sirtuins	T116,T126	C1136177
27651178	426	434	oxidized	T044	C0030011
27651178	435	499	nicotinamide adenine dinucleotide (NAD(+))dependent deacetylases	T044	C2613148
27651178	514	523	metabolic	T169	C0311400
27651178	524	530	status	T080	C0449438
27651178	538	542	cell	T025	C0007634
27651178	544	550	SIRT 4	T116,T126	C2002817
27651178	568	588	regulatory functions	T038	C1327622
27651178	592	612	fatty acid oxidation	T044	C1158366
27651178	618	632	HELLP syndrome	T047	C0162739
27651178	642	657	associated with	T080	C0332281
27651178	658	668	short-term	T079	C0443303
27651178	669	676	hypoxia	T046	C0242184
27651178	681	688	studied	T062	C2603343
27651178	689	697	sirtuins	T116,T126	C1136177
27651178	699	705	SIRT 1	T116,T126	C1101544
27651178	707	713	SIRT 3	T116,T126	C1143857
27651178	719	725	SIRT 4	T116,T126	C2002817
27651178	730	736	HUVECs	T025	C3179121
27651178	742	765	pregnancies complicated	T047	C0032962
27651178	773	787	HELLP syndrome	T047	C0162739
27651178	792	805	uncomplicated	T080	C0443334
27651178	806	817	pregnancies	T040	C0032961
27651178	818	825	exposed	T080	C0332157
27651178	829	836	hypoxia	T046	C0242184
27651178	844	852	controls	T096	C0009932
27651178	856	861	HELLP	T047	C0162739
27651178	895	897	O2	T121,T123,T196	C0030054
27651178	900	907	Protein	T116,T123	C0033684
27651178	908	914	levels	T080	C0441889
27651178	918	924	SIRT 4	T116,T126	C2002817
27651178	930	943	significantly	T078	C0750502
27651178	944	950	higher	T080	C0205250
27651178	954	960	HUVECs	T025	C3179121
27651178	966	971	HELLP	T047	C0162739
27651178	972	980	compared	T052	C1707455
27651178	984	991	control	T096	C0009932
27651178	1020	1027	hypoxia	T046	C0242184
27651178	1033	1039	NAD(+)	T114,T121,T123	C0027270
27651178	1040	1046	levels	T080	C0441889
27651178	1047	1056	increased	T081	C0205217
27651178	1062	1066	time	T079	C0040223
27651178	1069	1078	dependent	T169	C3244310